Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer
Clinical trial NCT07267078 · RECRUITING
Trial details
- NCT number
- NCT07267078
- Sponsor
- Peking Union Medical College Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-25
- Primary completion
- 2028-01-25
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.